Clinical Nuclear Medicine · 2006 · 33 citations · 4 references
MedicineNuclear MedicineRadiologyMetastasisMolecular ImagingOncologic ImagingLung CancerLung MetastasisPulmonary EmbolismPulmonary ImagingPulmonary InflammationPulmonary Nuclear Imaging18F-fluorodeoxyglucose Imaging18F-fluorodeoxyglucose Positron Emission TomographyCancer-associated Pulmonary EmbolismFluorine-18 Fluorodeoxyglucose Positron Emission TomographyIncidental Pulmonary Embolism DetectionPulmonary Artery ImagingScavenger ReceptorsWhole-body Pet Imaging
Abnormal F-18 fluorodeoxyglucose (FDG) accumulation patterns in the lung in patients with cancer having whole-body F-18 FDG-PET/CT scanning for restaging purposes are usually associated with primary lung tumors or lung metastases. Other diagnoses include postobstructive pneumonia and/or atelectasis, granulomatous lung disease, or occult lung infarction. In the latter, enhanced F-18 FDG accumulation topographically matches otherwise proven areas of pulmonary embolism. We document focally enhanced F-18 FDG uptake in the thrombus in the right pulmonary artery in a patient with silent pulmonary embolism. We hypothesize that enhanced F-18 FDG accumulation is attributed to the inflammatory reaction and scavenger cell activity associated with the pathophysiological cascade in pulmonary embolism.
4
F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and Infection
Siema M. Bakheet, John Powe, Abdullah Al Amro et al. · Clinical Nuclear Medicine · 2000 · 168 citations
Ehab M. Kamel, Thomas McKee, Maria-Lucia Calcagni et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 47 citations · Full text